Registration reinforces Marketstrat’s commitment to building a structured market intelligence system for MedTech, medical imaging, imaging AI, and adjacent healthcare technology markets.
SACRAMENTO, Calif. — Apr. 28, 2026 — Marketstrat Inc. announced today that the United States Patent and Trademark Office has registered Markintel® as a service mark of Marketstrat Inc.
The registration marks an important milestone in Marketstrat’s development as an independent market intelligence firm focused on MedTech, medical imaging, imaging AI, enterprise imaging, PACS, and adjacent healthcare technology markets.
Markintel® represents Marketstrat’s research methodology and publishing system. It is the framework behind the firm’s Horizon Reports, Pulse Reports, Company Research, Market Signals, and weekly Pulse Insights. Together, these research formats are designed to help decision-makers interpret complex and fast-moving markets through structured analysis, transparent assumptions, and clear strategic implications.
The USPTO registration covers Class 35 services, including market research reports, market share analysis, market intelligence, competitive analysis, market sizing, market forecasts, and market research subscription services.
“Markintel is more than a brand name for us,” said Sudheer Yerabati, Founder of Marketstrat. “It reflects the intelligence system we are building — one that helps decision-makers move beyond information overload and connect fast-moving market signals to strategy.”
Marketstrat’s research spans both long-range market structure and time-sensitive market developments. Its Horizon Reports provide comprehensive market landscape assessments with sizing, segmentation, forecasting, and competitive mapping across multi-year time horizons. Pulse Reports focus on specific segments, technologies, or competitive dynamics. Company Research provides decision-grade intelligence on individual companies. Market Signals analyze specific catalysts, including regulatory actions, M&A, product launches, policy shifts, reimbursement changes, and earnings. Pulse Insights provides a weekly digest of what moved, what it means, and what to watch.
The Markintel® registration comes at a time when healthcare and life sciences decision-makers face an expanding volume of information, vendor claims, AI-generated content, regulatory developments, and competitive activity. Marketstrat’s goal is to help readers separate signal from noise by combining elements of sell-side research discipline, commercial market research, competitive intelligence, and strategic analysis.
Marketstrat’s published research is increasingly being read by a broad cross-section of stakeholders across the healthcare technology ecosystem, including MedTech corporate strategy teams, medical imaging and AI companies, investors, consultants, analysts, and industry media professionals. Marketstrat’s research is distributed through its own channels and select research distribution platforms used by corporate strategy, investment, consulting, and healthcare technology professionals.
“In an age where information is easier to generate, interpretation becomes more valuable,” Yerabati added. “Our work is focused on building frameworks that help readers understand not only what happened, but why it matters and how it may shape market opportunity, competition, and commercialization.”
The Markintel® registration follows Marketstrat’s earlier USPTO registration of the Marketstrat® service mark and reinforces the company’s commitment to building trusted, structured intelligence for healthcare technology decision-makers.
About Marketstrat
Marketstrat® is an independent market intelligence firm focused on MedTech, medical imaging, imaging AI, enterprise imaging, PACS, and adjacent healthcare technology markets. Through its Markintel® research methodology and publishing system, Marketstrat produces Horizon Reports, Pulse Reports, Company Research, Market Signals, and weekly Pulse Insights. The firm’s research combines market sizing, forecasting, segmentation, competitive mapping, company intelligence, and event-driven analysis to help corporate strategy, product, commercial, investment, consulting, and industry media professionals interpret fast-moving healthcare markets with greater clarity.
Marketstrat® and Markintel® are registered service marks of Marketstrat Inc.
